Maternal health conditions during pregnancy and acute leukemia in children with down syndrome: a children's oncology group study

Pediatric Blood and Cancer

Volumn 52, Issue 5, 2009, Pages 602-608

  Ognjanovic, Simona ^a,b,f   Puumala, Susan ^a   Spector, Logan G ^a,b   Smith, Franklin O ^c   Robison, Leslie L ^d   Olshan, Andrew F ^e   Ross, Julie A ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e IL   (United States)

^f NONE   (United States)

Author keywords

Down syndrome; Inflammation; Leukemia

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AMNIOCENTESIS; ARTICLE; CANCER RISK; CHILD; CONTROLLED STUDY; DOWN SYNDROME; GESTATION PERIOD; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL WELFARE; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; URINARY TRACT INFECTION; VAGINA BLEEDING; CASE CONTROL STUDY; FEMALE; MALE; RISK FACTOR; STATISTICS;

ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MATERNAL WELFARE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREGNANCY; RISK FACTORS;

EID: 63649113476     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21914     Document Type: Article

References (40)

1. Sinniah D, D'Anaio GJ, Chatten J, et al. editors. Atlas of pediatric oncology. London: Arnold; 1996.
2. Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 2000;355:165 -169.
3. Okuda T, Cai Z, Yang S, et al. Expression of a knocked-in AML1- ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Blood 1998;91:3134-3143.
4. Ross JA. Epidemiologic studies of childhood leukemia: Where do we go from here? Med Pediatr Oncol 1999;32:65 -67.
5. Scholl T, Stein Z, Hansen H. Leukemia and other cancers, anomalies and infections as causes of death in Down's syndrome in the United States during 1976. Dev Med Child Neurol 1982;24:817-829.
6. Belson M, Kingsley B, Holmes A. Risk factors for acute leukemia in children: A review. Environ Health Perspect 2007;115:138-145.
7. Alderton LE, Spector LG, Blair CK, et al. Child and maternal household chemical exposure and the risk of acute leukemia in children with Down's syndrome: A report from the Children's Oncology Group. Am J Epidemiol 2006;164:212-221.
8. Canfield KN, Spector LG, Robison LL, et al. Childhood and maternal infections and risk of acute leukaemia in children with Down syndrome: A report from the Children's Oncology Group. Br J Cancer 2004;91:1866-1872.
9. Linabery AM, Olshan AF, Gamis AS, et al. Exposure to medical test irradiation and acute leukemia among children with Down syndrome: A report from the Children's Oncology Group. Pediatrics 2006;118:e1499-e1508.
10. Mejia-Arangure JM, Fajardo-Gutierrez A, Perez-Saldivar ML, et al. Magnetic fields and acute leukemia in children with Down syndrome. Epidemiology 2007;18:158-161.
11. Puumala SE, Ross JA, Olshan AF, et al. Reproductive history, infertility treatment, and the risk of acute leukemia in children with down syndrome: A report from the Children's Oncology Group. Cancer 2007;110:2067-2074.
12. Ross JA, Blair CK, Olshan AF, et al. Periconceptional vitamin useand leukemia risk in children with Down syndrome: A Children's Oncology Group study. Cancer 2005;104:405-410.
13. Greaves MF. Speculations on the cause of childhood acute lymphoblastic leukemia. Leukemia 1988;2:120-125.
14. Greaves MF. Aetiology of acute leukaemia. Lancet 1997;349:344-349.
15. Greaves MF, Alexander FE. An infectious etiology for common acute lymphoblastic leukemia in childhood? Leukemia 1993;7:349-360.
16. Jourdan-Da SilvaN, Perel Y, Mechinaud F, et al. Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia. Br J Cancer 2004;90:139-145.
17. McKinney PA, Juszczak E, Findlay E, et al. Pre- and perinatal risk factors for childhood leukaemia and other malignancies: A Scottish case control study. Br J Cancer 1999;80:1844-1851.
18. Schuz J, Kaletsch U, Meinert R, et al. Association of childhood leukaemia with factors related to the immune system. Br J Cancer 1999;80:585 -590.
19. Hayes A, Batshaw ML. Down syndrome. Pediatr Clin North Am 1993;40:523 -535.
20. Lockitch G, Singh VK, Puterman ML, et al. Age-related changes in humoral and cell-mediated immunity in Down syndrome children living at home. Pediatr Res 1987;22:536-540.
21. Roizen NJ, Amarose AP. Hematologic abnormalities in children with Down syndrome. Am J Med Genet 1993;46:510-512.
22. Cuadrado E, Barrena MJ. Immune dysfunction in Down's syndrome: Primary immune deficiency or early senescence of the immune system? Clin Immunol Immunopathol 1996;78:209- 214.
23. Novo E, Garcia MI, Lavergne J. Nonspecific immunity in Down syndrome: A study of chemotaxis, phagocytosis, oxidative metabolism, and cell surface marker expression of polymorphonuclear cells. Am J Med Genet 1993;46:384-391.
24. Cuckle H, Wald N, Stone R, et al. Maternal serum thyroid antibodies in early pregnancy and fetal Down's syndrome. Prenat Diagn 1988;8:439-445.
25. Fialkow PJ, Hecht F, Uchida IA, et al. Increased frequency of thyroid autoantibodies in mothers of patients with Down's syndrome. Lancet 1965;2:868-870.
26. Khoury MJ, Becerra JE, d'Almada PJ. Maternal thyroid disease and risk of birth defects in offspring: A population-based case- control study. Paediatr Perinat Epidemiol 1989;3:402-420.
27. Zeller B, Gustafsson G, Forestier E, et al. Acute leukaemia in children with Down syndrome: A population-based Nordic study. Br J Haematol 2005;128:797-804.
28. Wan W, Shimizu S, Ikawa H, et al. Maternal cell traffic bounds for immune modulation: Tracking maternal H-2 alleles in spleens of baby mice by DNA fingerprinting. Immunology 2002;107:261 -267.
29. Reisenberger K, Egarter C, Vogl S, et al. The transfer of interleukin- 8 across the human placenta perfused in vitro. Obstet Gynecol 1996;87:613-616.
30. Zaretsky MV, Alexander JM, Byrd W, et al. Transfer of inflammatory cytokines across the placenta. Obstet Gynecol 2004;103:546-550.
31. Radaelli T, Varastehpour A, Catalano P, et al. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 2003;52:2951 -2958.
32. Depino AM. Maternal infection and the offspring brain. J Neurosci 2006;26:7777-7778.
33. Buka SL, Goldstein JM, Spartos E, et al. The retrospective measurement of prenatal and perinatal events: Accuracy of maternal recall. Schizophr Res 2004;71:417-426.
34. Infante-Rivard C, Jacques L. Empirical study of parental recall bias. Am J Epidemiol 2000;152:480-486.
35. Olson JE, Shu XO, Ross JA, et al. Medical record validation of maternally reported birth characteristics and pregnancy-related events: A report from the Children's Cancer Group. Am J Epidemiol 1997;145:58-67.
36. Hunt KJ, Schuller KL. The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am 2007;34:173-199. vii.
37. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1 -S22.
38. Gomez R, Romero R, Nien JK, et al. A short cervix in women with preterm labor and intact membranes: A risk factor for microbial invasion of the amniotic cavity. Am J Obstet Gynecol 2005;192: 678-689.
39. Liu L, Krailo M, Reaman GH, et al. Childhood cancer patients' access to cooperative group cancer programs: A population-based study. Cancer 2003;97:1339-1345.
40. Ross JA, Severson RK, Pollock BH, et al. Childhood cancer in the United States. A. geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups. Cancer 1996;77:201 -207.